Heterocyclic FXR binding compounds

Details for Australian Patent Application No. 2007291514 (hide)

Owner Phenex Pharmaceuticals AG

Inventors Kremoser, Claus; Schulz, Andreas; Abel, Ulrich; Deuschle, Ulrich

Agent Shelston IP

Pub. Number AU-B-2007291514

PCT Pub. Number WO2008/025540

Priority 06018023.9 29.08.06 EP; 60/840,775 29.08.06 US

Filing date 29 August 2007

Wipo publication date 6 March 2008

Acceptance publication date 16 June 2011

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

12 March 2009 PCT application entered the National Phase

  PCT publication WO2008/025540 Priority application(s): WO2008/025540

16 June 2011 Application Accepted

  Published as AU-B-2007291514

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007291515-Polymorph of (R) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-s-ylcarbamoyl-methyl) - 1-azoni a-bicyclo- [2.2.2] octane bromide

2007291509-Controlled release oral dosage formulations comprising a core and one or more barrier layers